UBS Group’s ImageneBio IMA Stock Holding History
Bought
Maintained
Sold
Other funds holding IMA
BCM
UBS Group's IMA Position: Q3 2026 in Review
UBS Group increased its ImageneBio (IMA) stake by 4.1% in Q3 2026, buying an estimated $1.54K and bringing the position to 7,163 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #8018.
UBS Group first reported a position in IMA in Q1 2021 and has held it in 17 quarters since. The position peaked at $129K in Q1 2025. 30 funds tracked by Wall St. Rank hold IMA as of Q3 2026.
- UBS Group held 7,163 shares of ImageneBio worth $32.8K as of Q3 2026.
- UBS Group bought 284 ImageneBio shares in Q3 2026, an estimated $1.54K.
- ImageneBio made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8018 holding.
- UBS Group first reported a position in ImageneBio in Q1 2021 and has held it in 17 quarters since.
- UBS Group's ImageneBio position peaked at $129K in Q1 2025.
- 30 funds tracked by Wall St. Rank held ImageneBio as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.